Search Results for: hepatitis C virus

March 12, 2015March 12, 2015

Success of Salvage Liver Transplantation Depends on Time to Recurrence

Hepatitis B, News

With a long liver transplant wait list for patients with hepatocellular carcinoma due to hepatitis B virus, clinicians are keen to find alternative methods of treating their patients. For some ... Read more

March 4, 2015March 5, 2015

Serum Identified as a Key Factor in Chronic HBV Interferon Therapy Effectiveness

Hepatitis B, News

A recent study identified high levels of interleukin (IL)-23 in patients’ serum as a biomarker for chronic hepatitis B patients positive for hepatitis B e antigen (HBeAg) responding to pegylated ... Read more

March 3, 2015March 3, 2015

HBV Patients With Nucleotide Analogue Resistance May Benefit from TDF Monotherapy

Hepatitis B, News

Recent research reports that tenofovir disoproxil fumarate (TDF) therapy for long periods is efficient in Chinese patients with chronic hepatitis B virus (HBV) infection that have relapsed after therapy with multiple ... Read more

February 17, 2015February 17, 2015

Study Reveals That Chemotherapy or Immunosuppressive Treatment May Reactivate HBV

Hepatitis B, News

A new review on the effect of Chemotherapy or immunosuppressive therapy in reactivation of Hepatitis B virus infection entitled “Recent US Food and Drug Administration warnings on hepatitis B reactivation ... Read more

January 23, 2015January 23, 2015

Arrowhead’s Chronic HBV Infection Therapy Study Approved

News

Arrowhead Research Corporation has been cleared to start its modified multiple-dose study of ARC-520 in patients who suffer from chronic hepatitis B infection by the U.S. Food and Drug Administration (FDA). The ... Read more

December 5, 2014December 5, 2014

Bio-filtration Device Eliminates Immunosuppressive Proteins From HCV Individuals’ Circulatory Systems

Hepatitis C, News

San Diego based Aethlon Medical, Inc., an innovator in developing targeted therapeutic devices to address infectious disease and cancer, reported final clinical outcomes, including rapid virologic response (RVR) and sustained ... Read more

October 22, 2014October 22, 2014

Enanta Foregoes Co-development Option For Hep C Drug With AbbVie

Hepatitis C, News

Enanta Pharmaceuticals, Inc. has just announced it will forego its co-development option with AbbVie for their next-generation protease inhibitor, ABT-493, indicated for the treatment of hepatitis C. The CDC estimates that ... Read more

October 21, 2014October 22, 2014

Sovaldi Better for Cost Issues in Hep C Treatments for Inmates

Hepatitis C, News

The treatment of inmates remains a hot-button issue that includes a wide range of different considerations, ranging from how well cared-for a prisoner should be to the economics involved in maintaining ... Read more

About Us

Hepatitis is a chronic infection that continues to be a serious worldwide health issue. With Hepatitis B, 2 billion people (1 out of every 3 people) have the infection, and 400 million ... Read more